Akebia Therapeutics Inc, a United States-based biopharmaceutical company that specialises in dialysis and kidney care services, announced on Thursday that it has named LeAnne M Zumwalt as its new director effective 16 February 2021.
Zumwalt has served as group vice president, Government Affairs at DaVita Inc, where she has been employed for 20 years. She has also served on the Adeptus Health and The Advisory Board Company boards of directors.
John P Butler, Akebia Therapeutics president and chief executive officer, said, 'We're honoured to have LeAnne Zumwalt join the Akebia board of directors. Her deep knowledge of and expertise in the US dialysis market, in combination with the financial and public policy leadership roles she has held throughout her career, will be invaluable as we continue to advance our purpose and prepare for the launch of vadadustat, subject to approval.'
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer